Recombinant Erythropoietin Drugs
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2023
1 Recombinant Human Granulocyte Colony-Stimulating Market Overview
1.1 Product Overview and Scope of Recombinant Human Granulocyte Colony-Stimulating
1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Lenograstim (Granocyte)
1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.2.4 Others
1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application
1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application: (2022-2028)
1.3.2 Chemotherapy Induced Neutropenia
1.3.3 Before Blood Donation
1.3.4 Stem Cell Transplants
1.3.5 Others
1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2028
1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2028
1.4.3 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant Human Granulocyte Colony-Stimulating Market Competition by Manufacturers
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2017-2022)
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation and Trends
2.5.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players Market Share by Revenue
2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.4.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
3.5.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.6.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.6.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.7.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2022)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2017-2022)
5 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Application
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2017-2022)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Corporation Information
6.2.2 Qilu Pharmaceutical Description and Business Overview
6.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.2.5 Qilu Pharmaceutical Recent Developments/Updates
6.3 Shijiazhuang Pharmaceutical
6.3.1 Shijiazhuang Pharmaceutical Corporation Information
6.3.2 Shijiazhuang Pharmaceutical Description and Business Overview
6.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.3.5 Shijiazhuang Pharmaceutical Recent Developments/Updates
6.4 Kyowa Hakko Kirin
6.4.1 Kyowa Hakko Kirin Corporation Information
6.4.2 Kyowa Hakko Kirin Description and Business Overview
6.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.4.5 Kyowa Hakko Kirin Recent Developments/Updates
6.5 Gensci
6.5.1 Gensci Corporation Information
6.5.2 Gensci Description and Business Overview
6.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.5.5 Gensci Recent Developments/Updates
6.6 Amoytop Biotech
6.6.1 Amoytop Biotech Corporation Information
6.6.2 Amoytop Biotech Description and Business Overview
6.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.6.5 Amoytop Biotech Recent Developments/Updates
6.7 Hangzhou Jiuyuan
6.6.1 Hangzhou Jiuyuan Corporation Information
6.6.2 Hangzhou Jiuyuan Description and Business Overview
6.6.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.7.5 Hangzhou Jiuyuan Recent Developments/Updates
6.8 Huaxin
6.8.1 Huaxin Corporation Information
6.8.2 Huaxin Description and Business Overview
6.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.8.5 Huaxin Recent Developments/Updates
6.9 Triprime
6.9.1 Triprime Corporation Information
6.9.2 Triprime Description and Business Overview
6.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.9.5 Triprime Recent Developments/Updates
6.10 Sinovac
6.10.1 Sinovac Corporation Information
6.10.2 Sinovac Description and Business Overview
6.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.10.5 Sinovac Recent Developments/Updates
6.11 Zhaoke
6.11.1 Zhaoke Corporation Information
6.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview
6.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.11.5 Zhaoke Recent Developments/Updates
6.12 Kawin
6.12.1 Kawin Corporation Information
6.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview
6.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio
6.12.5 Kawin Recent Developments/Updates
7 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis
7.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
7.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List
8.3 Recombinant Human Granulocyte Colony-Stimulating Customers
9 Recombinant Human Granulocyte Colony-Stimulating Market Dynamics
9.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends
9.2 Recombinant Human Granulocyte Colony-Stimulating Market Drivers
9.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges
9.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints
10 Global Market Forecast
10.1 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Type (2023-2028)
10.2 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Application (2023-2028)
10.3 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation by Manufacturers in 2021
Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022) & (KG)
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2017-2022)
Table 19. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
Table 20. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
Table 21. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
Table 23. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
Table 24. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
Table 25. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2017-2022)
Table 31. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
Table 32. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
Table 33. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
Table 39. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
Table 40. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
Table 41. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2017-2022)
Table 43. Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2017-2022) & (USD/g)
Table 44. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2017-2022)
Table 45. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
Table 46. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Application (2017-2022)
Table 48. Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2017-2022) & (USD/g)
Table 49. Amgen Corporation Information
Table 50. Amgen Description and Business Overview
Table 51. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 52. Amgen Recombinant Human Granulocyte Colony-Stimulating Product
Table 53. Amgen Recent Developments/Updates
Table 54. Qilu Pharmaceutical Corporation Information
Table 55. Qilu Pharmaceutical Description and Business Overview
Table 56. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 57. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product
Table 58. Qilu Pharmaceutical Recent Developments/Updates
Table 59. Shijiazhuang Pharmaceutical Corporation Information
Table 60. Shijiazhuang Pharmaceutical Description and Business Overview
Table 61. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 62. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product
Table 63. Shijiazhuang Pharmaceutical Recent Developments/Updates
Table 64. Kyowa Hakko Kirin Corporation Information
Table 65. Kyowa Hakko Kirin Description and Business Overview
Table 66. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 67. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product
Table 68. Kyowa Hakko Kirin Recent Developments/Updates
Table 69. Gensci Corporation Information
Table 70. Gensci Description and Business Overview
Table 71. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 72. Gensci Recombinant Human Granulocyte Colony-Stimulating Product
Table 73. Gensci Recent Developments/Updates
Table 74. Amoytop Biotech Corporation Information
Table 75. Amoytop Biotech Description and Business Overview
Table 76. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 77. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product
Table 78. Amoytop Biotech Recent Developments/Updates
Table 79. Hangzhou Jiuyuan Corporation Information
Table 80. Hangzhou Jiuyuan Description and Business Overview
Table 81. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 82. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product
Table 83. Hangzhou Jiuyuan Recent Developments/Updates
Table 84. Huaxin Corporation Information
Table 85. Huaxin Description and Business Overview
Table 86. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 87. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product
Table 88. Huaxin Recent Developments/Updates
Table 89. Triprime Corporation Information
Table 90. Triprime Description and Business Overview
Table 91. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 92. Triprime Recombinant Human Granulocyte Colony-Stimulating Product
Table 93. Triprime Recent Developments/Updates
Table 94. Sinovac Corporation Information
Table 95. Sinovac Description and Business Overview
Table 96. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 97. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product
Table 98. Sinovac Recent Developments/Updates
Table 99. Zhaoke Corporation Information
Table 100. Zhaoke Description and Business Overview
Table 101. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 102. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product
Table 103. Zhaoke Recent Developments/Updates
Table 104. Kawin Corporation Information
Table 105. Kawin Description and Business Overview
Table 106. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 107. Kawin Recombinant Human Granulocyte Colony-Stimulating Product
Table 108. Kawin Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Recombinant Human Granulocyte Colony-Stimulating Distributors List
Table 112. Recombinant Human Granulocyte Colony-Stimulating Customers List
Table 113. Recombinant Human Granulocyte Colony-Stimulating Market Trends
Table 114. Recombinant Human Granulocyte Colony-Stimulating Market Drivers
Table 115. Recombinant Human Granulocyte Colony-Stimulating Market Challenges
Table 116. Recombinant Human Granulocyte Colony-Stimulating Market Restraints
Table 117. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2023-2028) & (KG)
Table 118. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2023-2028) & (KG)
Table 122. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2023-2028) & (KG)
Table 126. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Granulocyte Colony-Stimulating
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2021 & 2028
Figure 3. Lenograstim (Granocyte) Product Picture
Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2021 & 2028
Figure 7. Chemotherapy Induced Neutropenia
Figure 8. Before Blood Donation
Figure 9. Stem Cell Transplants
Figure 10. Others
Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size (2017-2028) & (US$ Million)
Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales (2017-2028) & (KG)
Figure 14. Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers in 2021
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players: Market Share by Revenue in 2021
Figure 17. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)
Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2021
Figure 20. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2017-2022)
Figure 21. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2021
Figure 22. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Recombinant Human Granulocyte Colony-Stimulating
Figure 48. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
Figure 49. Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Qilu Pharmaceutical Shijiazhuang Pharmaceutical Kyowa Hakko Kirin Gensci Amoytop Biotech Hangzhou Jiuyuan Huaxin Triprime Sinovac Zhaoke Kawin